See more : AstraZeneca Pharma India Limited (ASTRAZEN.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Najran Cement Company (3002.SR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Najran Cement Company, a leading company in the Construction Materials industry within the Basic Materials sector.
You may be interested
- TDb Split Corp. (XTD.TO) Income Statement Analysis – Financial Results
- Frontier Services Group Limited (0500.HK) Income Statement Analysis – Financial Results
- Nien Hsing Textile Co., Ltd. (1451.TW) Income Statement Analysis – Financial Results
- Valson Industries Limited (VALSONQ.BO) Income Statement Analysis – Financial Results
- Scentre Group (SCG.AX) Income Statement Analysis – Financial Results
Najran Cement Company (3002.SR)
About Najran Cement Company
Najran Cement Company manufactures and sells cement products in the Kingdom of Saudi Arabia. The company offers ordinary Portland and cement resistant to salt. It also sells its products online. Najran Cement Company was founded in 2005 and is based in Najran, the Kingdom of Saudi Arabia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 485.65M | 535.69M | 581.55M | 623.20M | 416.41M | 278.41M | 346.24M | 710.46M | 1.09B | 827.89M | 631.64M | 613.35M | 697.45M | 634.69M | 373.23M | 198.77M |
| Cost of Revenue | 343.22M | 364.00M | 351.23M | 373.28M | 297.95M | 292.37M | 299.33M | 425.81M | 565.05M | 429.03M | 372.92M | 335.87M | 401.05M | 339.55M | 195.42M | 85.44M |
| Gross Profit | 142.43M | 171.69M | 230.32M | 249.92M | 118.45M | -13.95M | 46.91M | 284.65M | 521.60M | 398.86M | 258.72M | 277.48M | 296.41M | 295.15M | 177.81M | 113.33M |
| Gross Profit Ratio | 29.33% | 32.05% | 39.60% | 40.10% | 28.45% | -5.01% | 13.55% | 40.07% | 48.00% | 48.18% | 40.96% | 45.24% | 42.50% | 46.50% | 47.64% | 57.01% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 4.69M | 5.83M | 6.48M | 5.92M | 5.92M | 7.15M | 8.43M | 33.39M | 31.30M | 32.22M | 26.89M | 26.07M | 23.87M | 23.70M | 19.84M | 12.36M |
| Selling & Marketing | 2.26M | 1.65M | 5.57M | 3.34M | 1.58M | 456.00K | 1.56M | 91.16M | 181.03M | 86.72M | 5.95M | 6.90M | 9.19M | 4.94M | 3.64M | 0.00 |
| SG&A | 45.63M | 7.48M | 12.05M | 9.26M | 7.50M | 7.61M | 9.99M | 124.55M | 209.83M | 118.93M | 33.09M | 32.97M | 33.06M | 28.64M | 23.48M | 12.36M |
| Other Expenses | -1.87M | 35.51M | 41.02M | 29.96M | 25.13M | 16.00K | 5.15M | 2.53M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.74M | -3.64M | 0.00 |
| Operating Expenses | 44.70M | 42.99M | 53.07M | 39.22M | 32.63M | 35.01M | 33.73M | 124.55M | 209.83M | 127.77M | 42.00M | 32.97M | 33.06M | 31.37M | 19.84M | 12.36M |
| Cost & Expenses | 387.92M | 406.99M | 404.30M | 412.50M | 330.58M | 327.37M | 333.06M | 550.35M | 565.05M | 429.03M | 414.92M | 368.84M | 434.11M | 370.92M | 215.26M | 97.80M |
| Interest Income | 652.00K | 473.00K | 1.33M | 1.08M | 26.07M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 24.92M | 1.27M | 8.20M | 12.31M | 26.15M | 25.85M | 23.14M | 26.89M | 28.87M | 24.66M | 0.00 | 32.27M | 21.62M | 13.32M | 15.37M | 152.32M |
| Depreciation & Amortization | 81.17M | 74.96M | 73.88M | 76.19M | 77.38M | 92.92M | 111.02M | 117.60M | 128.62M | 115.73M | 80.27M | 86.48M | 82.50M | 85.82M | 80.43M | 19.18M |
| EBITDA | 179.81M | 205.75M | 253.09M | 282.81M | 162.70M | 43.70M | 124.20M | 277.71M | 443.25M | 398.86M | 305.90M | 330.99M | 340.66M | 348.49M | 251.99M | 120.14M |
| EBITDA Ratio | 37.02% | 36.60% | 43.56% | 45.44% | 39.19% | 15.37% | 35.51% | 39.23% | 48.00% | 48.18% | 48.43% | 53.96% | 49.72% | 54.91% | 67.51% | 60.44% |
| Operating Income | 97.73M | 128.38M | 180.94M | 208.64M | 84.18M | -49.22M | 7.90M | 160.11M | 521.60M | 398.86M | 225.63M | 244.51M | 264.26M | 262.67M | 171.56M | 100.96M |
| Operating Income Ratio | 20.12% | 23.96% | 31.11% | 33.48% | 20.21% | -17.68% | 2.28% | 22.54% | 48.00% | 48.18% | 35.72% | 39.86% | 37.89% | 41.38% | 45.97% | 50.80% |
| Total Other Income/Expenses | -22.15M | -8.01M | -9.93M | -16.34M | -25.66M | -26.88M | -18.46M | -20.87M | -23.50M | -143.66M | -8.91M | -32.27M | -20.71M | -14.42M | -1.78M | -152.32M |
| Income Before Tax | 75.59M | 120.37M | 171.01M | 193.97M | 59.66M | -76.09M | -10.56M | 133.22M | 285.76M | 255.20M | 216.72M | 212.24M | 242.63M | 249.35M | 156.18M | -51.36M |
| Income Before Tax Ratio | 15.56% | 22.47% | 29.41% | 31.12% | 14.33% | -27.33% | -3.05% | 18.75% | 26.30% | 30.83% | 34.31% | 34.60% | 34.79% | 39.29% | 41.85% | -25.84% |
| Income Tax Expense | 6.15M | 6.62M | 5.46M | -10.33M | 6.15M | 7.41M | 11.30M | 8.51M | 265.97M | 155.66M | 18.58M | 10.00M | 8.00M | 7.63M | 4.12M | 900.00K |
| Net Income | 69.43M | 112.81M | 165.55M | 200.94M | 53.52M | -83.50M | -21.86M | 124.71M | 255.62M | 243.20M | 198.14M | 202.24M | 234.63M | 241.72M | 152.07M | -52.26M |
| Net Income Ratio | 14.30% | 21.06% | 28.47% | 32.24% | 12.85% | -29.99% | -6.31% | 17.55% | 23.52% | 29.38% | 31.37% | 32.97% | 33.64% | 38.08% | 40.74% | -26.29% |
| EPS | 0.41 | 0.67 | 0.97 | 1.18 | 0.31 | -0.49 | -0.13 | 0.74 | 1.50 | 1.43 | 1.17 | 1.33 | 1.92 | 2.10 | 1.32 | -0.45 |
| EPS Diluted | 0.41 | 0.67 | 0.97 | 1.18 | 0.31 | -0.49 | -0.13 | 0.74 | 1.50 | 1.43 | 1.17 | 1.33 | 1.92 | 2.10 | 1.32 | -0.45 |
| Weighted Avg Shares Out | 170.00M | 170.00M | 170.00M | 170.00M | 170.00M | 170.00M | 170.00M | 170.00M | 170.00M | 170.00M | 169.35M | 152.06M | 122.21M | 115.10M | 115.20M | 116.13M |
| Weighted Avg Shares Out (Dil) | 170.00M | 170.00M | 170.00M | 170.00M | 170.00M | 170.00M | 170.00M | 170.00M | 170.42M | 170.00M | 169.35M | 152.06M | 122.21M | 115.10M | 115.20M | 116.13M |
No news found for: 3002.SR
Source: https://incomestatements.info
Category: Stock Reports